NCOA2 Antikörper (C-Term)
-
- Target Alle NCOA2 Antikörper anzeigen
- NCOA2 (Nuclear Receptor Coactivator 2 (NCOA2))
-
Bindungsspezifität
- AA 1169-1203, C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NCOA2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This NCOA2 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1169-1203 amino acids from the C-terminal region of human NCOA2.
- Klon
- RB50717
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product NCOA2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
- Target
- NCOA2 (Nuclear Receptor Coactivator 2 (NCOA2))
- Andere Bezeichnung
- NCOA2 (NCOA2 Produkte)
- Hintergrund
- Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain (AF- 2) but not of the modulating N-terminal domain (AF-1). Required with NCOA1 to control energy balance between white and brown adipose tissues.
- Molekulargewicht
- 159157
- UniProt
- Q15596
- Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Nuclear Hormone Receptor Binding, Regulation of Lipid Metabolism by PPARalpha, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling
-